10-Q: Palladyne AI Reports Q2 Loss Amid AI Pivot, Revenue Drop

Sentiment:

Quarterly Report


Palladyne AI Corp. reported a net loss for Q2 2025 despite a non-cash gain from warrant revaluation, as revenue significantly declined while the company continues its strategic pivot to AI/ML software.

Delay expectedSuccessful commercialization of AI/ML Foundational Technology and related products may be delayed beyond current expectations, impacting product availability, customer acquisition, and receipt of product revenue.The sales cycle for the company's products is likely to be between 12 and 18 months, or even longer, which is a significant delay in revenue realization.Changes in U.S. trade policy have caused some potential customers to re-evaluate automation priorities, which is expected to delay certain investment decisions in the near term.
Capital raiseThe company raised approximately $60.7 million in gross proceeds from the sale of common stock and warrants during the fourth quarter of 2024 and the first half of 2025.On November 1, 2024, the company closed a registered direct offering for 2,790,700 shares of common stock at $2.15 per share, and issued warrants to purchase up to 2,790,700 shares.In a separate concurrent private placement, the CEO and certain Board members purchased 430,105 shares of common stock at $2.20 per share and warrants to purchase up to 430,105 shares.On May 9, 2025, 2,790,700 of the 2024 Warrants were exercised, resulting in proceeds of $6.419 million.The company entered into an 'at-the-market' equity offering program with Jefferies LLC, selling $18.0 million of common stock by December 31, 2024, and an additional $29.3 million during the six months ended June 30, 2025.In July 2025, the company sold an additional 77,960 shares for approximately $0.7 million under the remaining capacity of the at-the-market program.The company states it may decide to seek additional financing to bolster cash reserves and pursue business objectives, and will be opportunistic in raising capital when market conditions are favorable.
Worse than expectedRevenue significantly decreased by 63% for the three months and 56% for the six months ended June 30, 2025, compared to the prior year periods, indicating a substantial decline in core business activity.The company continues to report operating losses, which increased to $8.094 million for Q2 2025 from $5.787 million in Q2 2024, and to $15.025 million for the six months ended June 30, 2025, from $13.140 million in the prior year, showing a worsening operational performance.The reported net income for the six-month period is primarily due to a non-cash gain from the revaluation of warrant liabilities, not from improved operational profitability, masking the underlying operational losses.

Summary

  • Palladyne AI Corp. is an early-stage company focused on developing and commercializing full-stack, closed-loop autonomy software (AI/ML Foundational Technology) for robotic systems in industrial and defense sectors.
  • The company reported a net loss of $7.487 million for the three months ended June 30, 2025, compared to a net loss of $5.323 million for the same period in 2024.
  • For the six months ended June 30, 2025, the company reported a net income of $15.272 million, primarily driven by a $29.351 million non-cash gain on warrant liabilities, compared to a net loss of $12.552 million in the prior year period.
  • Revenue decreased significantly by 63% to $1.015 million for the three months ended June 30, 2025, from $2.713 million in the prior year, mainly due to lower product development contract revenue.
  • For the six months ended June 30, 2025, revenue decreased by 56% to $2.725 million from $6.154 million in the prior year, attributed to reduced product development contracts and the absence of legacy hardware product sales.
  • Operating expenses increased by 7% to $9.109 million for Q2 2025, primarily due to a 33% increase in research and development expenses to $3.125 million, reflecting increased efforts in product testing, debugging, stabilization, and enhancements of software products.
  • Cash, cash equivalents, and marketable securities increased to $62.7 million as of June 30, 2025, from $40.1 million as of December 31, 2024, bolstered by recent capital raises.
  • Net cash used in operating activities for the six months ended June 30, 2025, was $12.842 million, a slight decrease from $13.033 million in the prior year period.
  • The company had an accumulated deficit of $475.6 million and working capital of $62.0 million as of June 30, 2025.
  • The sales cycle for Palladyne's AI/ML products is estimated to be between 12 and 18 months, or even longer, based on interactions with potential customers in the first half of 2025.
  • The company expects to begin generating revenues from commercial customers in 2025 and for revenues to grow modestly throughout 2026.

Sentiment

Score: 4

Explanation: The company is undergoing a significant strategic pivot to AI/ML software, which is a high-potential but also high-risk endeavor. While cash reserves have increased due to recent capital raises, operational revenue has significantly declined, and the company continues to incur substantial operating losses. The reported net income is primarily due to a non-cash gain from warrant revaluation, not core business profitability. Commercialization of new AI products is in early stages with long sales cycles and unproven market demand, indicating significant uncertainty and execution risk.

Positives

  • Cash, cash equivalents, and marketable securities increased to $62.7 million as of June 30, 2025, from $40.1 million at December 31, 2024, providing a stronger liquidity position.
  • The company believes it has sufficient financial resources to support operations for at least the next 12 months without needing to raise additional capital.
  • Net cash used in operating activities slightly decreased to $12.842 million for the six months ended June 30, 2025, from $13.033 million in the prior year, indicating a minor improvement in operational cash burn.
  • A significant non-cash gain of $29.351 million on warrant liabilities contributed to a net income for the six-month period, improving the overall financial statement appearance.
  • The company successfully raised approximately $60.7 million in gross proceeds from the sale of common stock and warrants during Q4 2024 and H1 2025, strengthening its capital base.
  • Initial commercial versions of Palladyne IQ and Palladyne Pilot products have been released, marking progress in the strategic pivot to AI/ML software.
  • The company achieved Level 2 certification under the Cybersecurity Maturity Model Certification (CMMC) program on April 10, 2025, which is crucial for securing DoD contracts.

Negatives

  • Revenue decreased significantly by 63% for the three months ended June 30, 2025, and 56% for the six months ended June 30, 2025, compared to the prior year periods.
  • The company continues to incur substantial operating losses, with a loss from operations of $8.094 million for Q2 2025 and $15.025 million for the six months ended June 30, 2025.
  • Product revenue was minimal for the current periods, and legacy hardware product sales did not recur, indicating a complete shift away from previous revenue streams without immediate replacement.
  • The company has a history of losses and negative cash flows from operations since inception, with an accumulated deficit of $475.6 million as of June 30, 2025.
  • The sales cycle for new AI/ML products is estimated to be long, between 12 and 18 months or even longer, delaying significant commercial revenue generation.
  • The reported net income for the six-month period is primarily due to a non-cash gain on warrant liabilities, not from improved operational profitability.
  • Research and development expenses increased by 33% in Q2 2025, indicating continued high investment without immediate revenue returns.

Risks

  • The company is an early-stage entity with a history of losses and expects to incur significant losses for the foreseeable future.
  • Operating and financial projections rely on management assumptions and analyses that may prove incorrect, leading to materially different actual results.
  • The ability to generate positive operating cash flow is uncertain, as the company has had negative cash flow from operations since inception.
  • No previous history or experience with commercializing software products, and past efforts to commercialize hardware technologies were unsuccessful.
  • Successful commercialization of AI/ML Foundational Technology and related products may be delayed beyond current expectations, impacting product availability, customer acquisition, and revenue receipt.
  • Anticipated revenues are expected to be primarily derived from the licensing of AI/ML software products, concentrating revenue risk.
  • Issues in the development and use of AI/ML Foundational Technology or related products, or issues in products developed by others, may result in reputational harm or liability.
  • The AI/ML Foundational Technology and related products are new technologies, making the timing and magnitude of revenues from customers uncertain.
  • The company may need to cease business operations if it cannot generate material revenues from software products before exhausting financial resources.
  • Failure to attract or retain customers at sufficient rates or numbers, or at all, is a significant risk.
  • The company has no previous history with its licensing sales model, and important assumptions about market demand, pricing, adoption rates, and sales cycles may be inaccurate.
  • Products related to AI/ML Foundational Technology require limited hardware components, and the company is dependent on single, sole, or limited source suppliers.
  • Operating in a competitive industry subject to rapid technological change, with expected increasing competition, means products may not remain competitive.
  • Inability to successfully enhance product offerings through research and development efforts could harm the business.
  • Real or perceived design flaws, errors, defects, glitches, bugs, or malfunctions in AI/ML Foundational Technology could result in lower ROI for customers, personal injury, property damage, and security/safety concerns.
  • Use of 'open source' software could negatively affect the ability to offer AI/ML Foundational Technology and subject the company to litigation.
  • Business and prospects depend significantly on the ability to build brand; negative publicity could harm brand and reputation.
  • Management team has broad discretion in strategic decisions, and past decisions have not always led to desired results; future decisions may also not be successful.
  • Failure to effectively manage the business could hinder the design, development, marketing, and commercialization of software products.
  • Inability to adequately control costs associated with operations to achieve profitability.
  • Substantial research and development costs are expected, and the company may never reach profitability or achieve significant licensing revenue.
  • Business plans require significant capital; additional equity or debt securities may be sold, diluting stockholders or introducing restrictive covenants.
  • Financial results may vary significantly from period to period due to fluctuations in operating costs, revenues, and product demand.
  • High dependence on senior management and other key employees; inability to attract, integrate, and retain qualified employees could harm the business.
  • Failure to maintain and strengthen effective systems of disclosure controls and procedures and internal control over financial reporting could adversely affect financial statements or compliance.
  • Risks associated with strategic relationships or transactions, and potential inability to identify or form desired strategic relationships in the future.
  • Potential exposure to new or changing governmental regulations relating to AI/ML technology, with non-compliance leading to delays, withdrawal of products, increased costs, or making the business unviable.
  • Subject to claims, lawsuits, arbitration proceedings, government investigations, and other legal/regulatory proceedings.
  • Subject to evolving laws, regulations, standards, policies, and contractual obligations related to data privacy and security, with non-compliance risking harm to reputation, fines, and liability.
  • Subject to cybersecurity risks to operational systems, security systems, infrastructure, and data.
  • As a government contractor or subcontractor, subject to specific laws, regulations, and contractual provisions, including DoD's CMMC program requirements.
  • Subject to U.S. and foreign anti-corruption and anti-money laundering laws and regulations.
  • Subject to governmental export and import controls and laws.
  • Increased scrutiny and changing expectations regarding environmental, social, and governance (ESG) practices and reporting.
  • Inability to obtain and maintain protection for intellectual property (patents, trademarks, trade secrets).
  • Potential intellectual property infringement or misappropriation claims.
  • Intellectual property discovered through government-funded programs may be subject to federal regulations like 'march-in' rights.
  • Potential damages from claims of wrongful use or disclosure of alleged trade secrets of employees' former employers.
  • Issuance or sale of common stock or rights to acquire common stock could depress trading price and cause dilution.
  • Price of common stock could decline due to large number of shares subject to employee equity awards.
  • Publicly traded securities have been volatile and may not continue to trade actively.
  • Potential delisting from Nasdaq Global Market if continued listing requirements are not met.
  • Cessation of research or changes in recommendations by industry/securities analysts could impact stock price.
  • No guarantee that deSPAC Public Warrants or deSPAC Private Placement Warrants will ever be in the money, and they may expire worthless.
  • Ability to redeem unexpired deSPAC Warrants prior to their exercise at a disadvantageous time for holders.
  • Exercise of deSPAC Warrants and 2024 Warrants would increase shares eligible for future resale and result in dilution.
  • Anti-takeover provisions in Charter and Bylaws, and Delaware law, could impair takeover attempts.
  • Bylaws provide Delaware courts as exclusive forum for certain stockholder litigation, potentially limiting stockholders' ability to obtain favorable judicial forum.
  • As an 'emerging growth company,' the company takes advantage of certain exemptions from reporting requirements, which may make its financial statements difficult to compare with other public companies.

Future Outlook

The company expects to begin generating revenues from commercial customers in 2025 and anticipates modest revenue growth throughout 2026. It plans to continue advancing and evolving its AI/ML technology and products in response to customer demands. The sales cycle for its products is projected to be between 12 and 18 months or longer. The company believes it has sufficient financial resources for at least the next 12 months and will continue to monitor market conditions for opportunistic capital raises. Future capital requirements will depend on development efforts, sales and marketing expansion, revenue growth, customer retention, and market acceptance of new product offerings.

Management Comments

  • We believe we have sufficient financial resources for at least the next 12 months from the date of this report.
  • We expect to begin generating revenues from commercial customers in 2025 and for revenues to grow modestly throughout 2026.
  • For the time being, we intend to take on only those development contracts that we believe support and contribute to our AI/ML Foundational Technology and related product development efforts.
  • We believe that our initial customer base will be comprised of innovators and early adopters in the industrial manufacturing, defense, infrastructure maintenance, repair and surveillance, energy and aerospace and aviation industries.
  • We believe that if we are successful in demonstrating the value of our products with these early adopters, there will be many potential customers that follow.
  • Based on interaction with dozens of potential customers during the first half of 2025, we believe that the sales cycle for our products is likely to be between 12 and 18 months, or even longer.
  • System integrators and potential customers of Palladyne IQ have indicated that recent changes in U.S. trade policy have caused some potential customers to re-evaluate their automation priorities which we believe will delay certain investment decisions in the near term but will overall create greater opportunities for Palladyne IQ deployments in the United States in the medium and long term.
  • We have taken many steps to reduce our use of cash. For example, we suspended our hardware product development efforts and focused our product development efforts on our AI/ML Foundational Technology and related products, conducted the 2023 RIFs and terminated our operations in Pittsburgh, Pennsylvania.
  • We plan to use our existing capital to further commercialize and conduct sales and marketing efforts for Palladyne IQ and Palladyne Pilot, as well as continue product testing, debugging and stabilization efforts and conduct product development efforts for the next versions of our products.

Industry Context

Palladyne AI Corp. operates in the rapidly evolving AI/ML software and robotics industries, targeting industrial and defense sectors. The company's pivot from hardware to software aligns with the increasing demand for AI-driven automation solutions. However, the market for its specific full-stack autonomy software is new and unproven, facing competition from both established industrial robotics manufacturers and emerging AI/ML technology companies. The long sales cycles and the need for customer adoption of new technologies are common challenges in this innovative space. Geopolitical factors and U.S. trade policy changes are noted as influencing customer investment decisions, potentially delaying near-term adoption but creating long-term opportunities for domestic deployments.

Comparison to Industry Standards

  • The company believes its 'human-like' ability to learn, reason, and adapt, enabled by its AI/ML Foundational Technology operating 'on the edge,' will be a key differentiator in assisting customers to enhance productivity in dynamic or unstructured environments.
  • Palladyne AI's products are designed to be hardware agnostic, aiming to function on a wide variety of industrial robots, cobots, UAVs, UGVs, and ROVs with minimal integration effort, which could offer a competitive advantage over less flexible solutions.
  • The company believes its AI/ML Foundational Technology and related products will compete with companies such as Bright Machines, Intrinsic, Liquid AI, Mujin, Physical Intelligence, Rapid Robotics, Skild AI, Anduril, and Shield AI, most of whom are focused on specific aspects rather than a fully competitive solution.
  • Industrial robotics and cobot manufacturers (e.g., ABB, Fanuc, Kawasaki, KUKA, Universal Robots, Yasakawa), large system integrators (e.g., Honeywell, Reply, Rockwell Automation), and technology companies (e.g., NVIDIA) are identified as potential target customers and/or partners, but also as potential formidable competitors through their own development or acquisitions.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
President and Chief Executive OfficerN/A (rejoined)Benjamin G. WolffJanuary 1, 2025 (term extension); February 2024 (rejoined)Extension of employment term and rejoining executive team following business pivot to AI/ML Foundational Technology.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Policy AmendmentAmended and Restated Outside Director Compensation Policy became effective, formalizing cash and equity compensation for non-employee directors, including annual cash retainers and automatic restricted stock unit grants.April 7, 2025Aims to attract, retain, and reward Outside Directors by providing competitive compensation, including performance-based vesting upon change of control, aligning their interests with stockholders.
Plan AdoptionAdopted the 2024 Inducement Equity Incentive Plan exclusively for grants to new or returning employees/directors as an inducement for employment, without stockholder approval per Nasdaq Listing Rule 5635(c)(4).December 15, 2024Provides flexibility to attract key talent, particularly AI/ML software engineers, by offering equity incentives outside of the main equity plan, which could help in talent acquisition but also lead to potential dilution.
Bylaw ProvisionBylaws designate the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain stockholder litigation matters.N/A (existing provision)May limit stockholders' ability to choose a judicial forum they find favorable for disputes, potentially discouraging lawsuits but also centralizing legal proceedings.
Bylaw ProvisionBylaws designate federal district courts of the United States as the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act.N/A (existing provision)Aims to streamline litigation related to federal securities laws, but its enforceability for Securities Act claims is uncertain as investors cannot waive compliance with federal securities laws.

Legal Proceedings

  • The company is not currently a party to or aware of any legal proceedings that are believed to have a material adverse effect on its business, financial condition, or results of operations.
  • No material loss contingency related to legal proceedings has been recorded as of June 30, 2025, and December 31, 2024.
  • The company may be subject to various claims, lawsuits, investigations, and other proceedings in the normal course of business, which could result in defense and settlement costs and diversion of management resources.

Related Party Transactions

  • On November 1, 2024, the company's Chief Executive Officer and certain other members of the Board of Directors purchased 430,105 shares of common stock and warrants to purchase up to 430,105 shares of common stock in a concurrent private placement.
  • Benjamin Wolff's employment agreement includes a phantom equity award (common stock equivalent of 1.5 million shares) subject to cliff vesting through October 31, 2027, which was subsequently replaced by a restricted stock award of 1.5 million shares on July 2, 2025.

Stakeholder Impact

  • **Shareholders**: Face potential dilution from future equity offerings and warrant exercises. The stock price is subject to high volatility due to the company's early stage, unproven commercialization, and mixed financial results. Anti-takeover provisions may limit certain shareholder actions.
  • **Employees**: Experienced workforce reductions in 2023, which placed strain on existing personnel. The company faces challenges in attracting and retaining highly qualified AI/ML software engineers due to intense competition and its location. Stock-based compensation is a key component of employee incentives.
  • **Customers**: New AI/ML products are in early commercialization with long sales cycles, requiring customers to adopt new technologies. Product performance, reliability, and safety are critical for customer satisfaction and adoption. U.S. trade policy changes may delay investment decisions for some customers.
  • **Suppliers**: The company's dependence on single, sole, or limited source suppliers for hardware components creates supply chain risks, potentially impacting costs and product availability.
  • **Creditors**: The company currently has no debt, but future capital raises through debt financing could introduce covenants that restrict operations.

Next Steps

  • Continue commercialization efforts, internal testing, and customer trials for Palladyne IQ and Palladyne Pilot products throughout 2025.
  • Advance and evolve AI/ML technology and products in response to evolving customer demands.
  • Continue product testing, debugging, and stabilization efforts for current products.
  • Conduct product development efforts for the next versions of Palladyne IQ and Palladyne Pilot.
  • Focus on generating revenues from commercial customers, with modest growth expected throughout 2026.
  • Monitor liquidity, financial and business results, and market conditions for opportunistic capital raises.
  • Evaluate the full impact of the 'One Big Beautiful Bill Act' (new tax legislation) on the company.
  • Comply with the Cybersecurity Maturity Model Certification (CMMC) program requirements, with all new DoD contracts expected to require compliance by 2026, and undergo periodic recertification.

Key Dates

DateDescription
December 31, 2023Balance sheet date for comparison.
February 2024Benjamin G. Wolff rejoined the executive team as President and Chief Executive Officer.
March 2024Company changed its name from Sarcos Technology and Robotics Corporation to Palladyne AI Corp.
April 17, 2024Company amended certain stock options, resulting in an incremental fair value of $0.2 million.
November 1, 2024Company closed a registered direct offering and concurrent private placement, issuing 2024 Warrants to purchase up to 3,220,805 shares of common stock.
November 13, 2024Company entered into an at-the-market equity offering program with Jefferies LLC to sell up to $18.0 million of common stock.
December 15, 2024Effective date of the 2024 Inducement Equity Incentive Plan.
December 2024Offerings under the 2021 Employee Stock Purchase Plan commenced.
December 31, 2024Balance sheet date for comparison; company filed a prospectus supplement for an additional $30.0 million of shares under the at-the-market program.
January 1, 2025Benjamin G. Wolff's extended term of employment as President and CEO became effective.
April 7, 2025Effective date of the Amended and Restated Outside Director Compensation Policy.
April 10, 2025Company received Level 2 certification under the Cybersecurity Maturity Model Certification (CMMC) program.
May 9, 20252,790,700 of the 2024 Warrants were exercised, generating $6.419 million in proceeds.
June 30, 2025End of the quarterly period covered by the report.
July 2, 2025Company granted Benjamin Wolff a restricted stock award of 1.5 million shares, reducing his phantom equity award to zero.
July 4, 2025President Trump signed the One Big Beautiful Bill Act, a new tax reform legislation.
July 29, 2025Date for the reported number of outstanding common stock shares (41,948,874).
August 6, 2025Filing date of the Quarterly Report on Form 10-Q.
September 24, 2026Expiration date of the deSPAC Warrants.
January 1, 2026Effective date for ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures.
December 15, 2026Effective date for ASU No. 2024-03, Income Statement-Reporting Comprehensive Income-Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses for fiscal years.
December 15, 2027Effective date for ASU No. 2024-03 for interim periods.

Recommendation

hold

Palladyne AI is in a critical transition phase, pivoting entirely to AI/ML software from its legacy hardware business. While the company has significantly bolstered its cash reserves through recent capital raises, providing a runway for operations, its core operational revenue has sharply declined, and it continues to incur substantial operating losses. The reported net income for the six-month period is a non-cash accounting gain from warrant revaluation, not indicative of underlying business profitability. The success of the new AI/ML products (Palladyne IQ and Pilot) is unproven, with long sales cycles (12-18+ months) and intense competition in a rapidly evolving market. This presents a high-risk, high-reward scenario. Given the significant execution risk associated with commercializing new technology in a competitive landscape and the current lack of sustainable operational revenue, a 'hold' recommendation is appropriate. Investors should monitor progress on commercialization, customer adoption, and the path to operational profitability before considering further investment.

Keywords

AI software, Machine Learning, Robotics, Autonomy software, Industrial automation, Defense technology, SEC filing, 10-Q, Financial results, Quarterly report, PDYN, Palladyne AI, Software licensing, Emerging growth company, Corporate governance, Risk factors, Capital raise, Warrants

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.